Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Biobran MGN-3 reduces chemotherapy side effects and improves quality of life for breast cancer patients.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

JAK inhibitors are effective treatments for alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A new microneedle patch effectively and safely treats alopecia areata.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Nifedipine may help treat perniosis, improving symptoms and clearing lesions for some patients.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Low-dose naltrexone helps improve symptoms and stabilize frontal fibrosing alopecia and lichen planopilaris.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The combination therapy significantly improved Riehl’s melanosis in patients without serious side effects.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Nanomedicines could offer better, longer-lasting psoriasis treatments with fewer side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A medication for skin rash also unexpectedly treated hair loss in a patient.